Difference between revisions of "DPYD-AS2"

From LncRNAWiki
Jump to: navigation, search
Line 4: Line 4:
 
DPYD-AS2:DPYD antisense RNA 2
 
DPYD-AS2:DPYD antisense RNA 2
  
NST00000422259<ref name="ref1" />
+
ENST00000422259 <ref name="ref1" />
 +
 
 
===Characteristics===
 
===Characteristics===
NST00000422259 is a DPYD (dihydropyrimidine dehydrogenase, a pyrimidinecatabolic pathway gene) intronic antisense lncRNA<ref name="ref1" />
+
ENST00000422259 is a DPYD (dihydropyrimidine dehydrogenase, a pyrimidinecatabolic pathway gene) intronic antisense lncRNA <ref name="ref1" />.
  
===Cellular Localization===
+
===Diseases===
 
+
Cervical squamous cancers <ref name="ref1" />
 
 
===Function===
 
  
===Regulation===
 
 
===Diseases===
 
Cervical squamous cancers<ref name="ref1" />
 
 
===Expression===
 
===Expression===
NST00000422259 is significantly upregulated expressed  in SiHa/ΔNp63αstable cell lines.<ref name="ref1" />
+
ENST00000422259 is significantly upregulated in SiHa/ΔNp63αstable cell lines <ref name="ref1" />.
  
 
===Sequence===
 
===Sequence===

Revision as of 02:59, 30 August 2017

Annotated Information

Name

DPYD-AS2:DPYD antisense RNA 2

ENST00000422259 [1]

Characteristics

ENST00000422259 is a DPYD (dihydropyrimidine dehydrogenase, a pyrimidinecatabolic pathway gene) intronic antisense lncRNA [1].

Diseases

Cervical squamous cancers [1]

Expression

ENST00000422259 is significantly upregulated in SiHa/ΔNp63αstable cell lines [1].

Sequence

>NR_046591.1 Homo sapiens DPYD antisense RNA 2 (DPYD-AS2), long non-coding RNA

000001 GGCAGCAGCA AGCTGATTAC ACAGGGAAAA GCTTCTATCT AAATACACAT AGCATAACAA TCACCCCTGG AAAAACTACA 000080
000081 TGGCTTACCA AAAGAGGTCT CTCTGTTCAC TGTCCATTAT CTGTTGACTG AACTAGTTCA AATGAATAAC AACCATACAA 000160
000161 ACACATATAT ACACAAATAT ACATATGCTT CAATGAAAAG CAGGCATGCA GCTGACAGCT CGGCAACCCT GAGCACAGAA 000240
000241 TTTTGAAGAG AGAATACACT AAAAGGGAAG AACATAACTA CATGACATCA TAAGAAGTCC TGAATTAGAA GCGTATATTT 000320
000321 GAAAGGTCAT GCATCCTGAG CTGCCAACAG CTTAACAACC AGAGGCAGAG GCCAGCTTTG CCAGCTCACT GCTTCTACTC 000400
000401 ATCTTTCATG ATAGTAGCCA GGCTGAATAT AGTTCCAGGA TGATAATGAA TTGGCTGGGC ATACTGTTTA TATTAGTATG 000480
000481 TATGTTCCTG TACTAAACCA AGCATCATGA GGCCAGCACT ATTTTGCCAT TTTTCAGAAA AAAAATATGA ACCCTTCAAA 000560
000561 ACATAGTAAG CCTTTTTTAA AGTATATATT TGATTTTGAA ATAATCAAAA TATATGTAGG GATATGACTG CATCCTAAGA 000640
000641 TTTATGATAA GTTCTGATGA GTAATATTTT CTTTCTACAT GCAAGGCAAA GTTAATAGTA ACTAGAAAGT CTTTATTTGG 000720
000721 CATATCATAG ATTTCTGTCA ACCAAAACAA CTAACTCTGG GGAACATAAC GTTCTGACAA CTTCAGAAGA GTTAAGTCAC 000800
000801 AGACAAAAGT TTATTGG

Labs working on this lncRNA

  • Department of Obstetrics and Gynecology, Anhui Provincial Hospital, Anhui Medical University, Hefei 230001, China.

References

  1. 1.0 1.1 1.2 1.3 Qian L, Xu F, Wang X, Jiang M, Wang J, Song W, Wu D, Shen Z, Feng D, Ling B, Cheng Y, Xiao W, Shan G, Zhou Y. LncRNA expression profile of ΔNp63α in cervical squamous cancers and its suppressive effects on LIF expression. Cytokine. 2017 Aug;96:114-122